July 29, 2008 – GE Healthcare reported results from a Phase I clinical trial of GE-067, a [18F]-labeled PET diagnostic imaging agent being developed by the company to assist in the detection of brain beta-amyloid were positive.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now